NCT00994409

Brief Summary

The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2008

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

October 13, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 14, 2009

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2010

Completed
Last Updated

December 1, 2010

Status Verified

November 1, 2010

Enrollment Period

2 years

First QC Date

October 13, 2009

Last Update Submit

November 30, 2010

Conditions

Stroke

Keywords

Stroke

Outcome Measures

Primary Outcomes (1)

  • Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness.

    September 2010

Secondary Outcomes (4)

  • Compliance/adherence with discharge medication Activities of daily living

    September 2010

  • Re-events

    September 2010

  • Degree of Disability

    September 2010

  • Mortality

    September 2010

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Stroke and TIA patients treated at the Charite with acute stroke or TIA onset less than 7 days

You may qualify if:

  • all patients eligible

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. Neurology, Charité Campus Benjamin Franklin

Berlin, Germany

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Peter U Heuschmann, Professor

    Center for Stroke Research Berlin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 13, 2009

First Posted

October 14, 2009

Study Start

July 1, 2008

Primary Completion

July 1, 2010

Study Completion

November 1, 2010

Last Updated

December 1, 2010

Record last verified: 2010-11

Locations

DE(1)